Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Female sex, obesity, rapid weight loss, prior gallstones, and dyslipidemia remain established risk factors for gallstone formation
For refractory OIC in the setting of GLP-1 therapy, peripherally acting mu-opioid receptor antagonists (PAMORAs) like naloxegol (25 mg daily) may be appropriate [6]
Chuong et al., 2023
It is important to follow the dosage instructions provided by a healthcare professional, and the duration of treatment may vary based on individual response and weight management goals
US$ 28.64
US$ 22.26
US$ 27.58
US$ 29.59
US$ 21.07
US$ 29.57
US$ 23.91
